{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:29:44Z","timestamp":1792600184697,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017001","name":"Islamia University of Bahawalpur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ibroneuroreports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IBRO Neuroscience Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ibneur.2025.02.002","type":"journal-article","created":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T12:29:49Z","timestamp":1738672189000},"page":"270-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Advancing Alzheimer's Therapy: Computational strategies and treatment innovations"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7258-9113","authenticated-orcid":false,"given":"Jibon Kumar","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2596-0562","authenticated-orcid":false,"given":"Abbeha","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8937-0613","authenticated-orcid":false,"given":"Mahir","family":"Azmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Gulzar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Talal Rahim","family":"Afghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar Faruk","family":"Talukder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Shahzadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9045-3916","authenticated-orcid":false,"given":"Ajit","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ibneur.2025.02.002_bib1","first-page":"391","article-title":"Alzheimer\u2019s & dementia","volume":"16","author":"2020 Alzheimer\u2019s disease facts and figures","year":"2020"},{"key":"10.1016\/j.ibneur.2025.02.002_bib2","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.3390\/biomedicines11123304","article-title":"Deep learning-based prediction of Alzheimer\u2019s disease using microarray gene expression data","volume":"11","author":"Abdelwahab","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ibneur.2025.02.002_bib3","doi-asserted-by":"crossref","first-page":"7934442","DOI":"10.1155\/2022\/7934442","article-title":"Targeting oxidative stress mechanisms to treat alzheimer\u2019s and parkinson\u2019s disease: a critical review","volume":"2022","author":"Aborode","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.ibneur.2025.02.002_bib4","first-page":"8","article-title":"Machine learning for neuroimaging with scikit-learn","author":"Abraham","year":"2014","journal-title":"Front. Neuroinform"},{"key":"10.1016\/j.ibneur.2025.02.002_bib5","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s12010-021-03779-3","article-title":"In silico molecular docking approach against enzymes causing alzheimer\u2019s disease using borassus flabellifer linn","volume":"194","author":"Abraham","year":"2022","journal-title":"Appl. Biochem Biotechnol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/2988685","article-title":"Claudia), 2024. In Silico investigation of novel compounds as inhibitors of acetylcholinesterase enzyme for the treatment of Alzheimer\u2019s diseases","author":"Adebambo","year":"2024","journal-title":"Int. J. Alzheimer\u2019S. Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib7","first-page":"2647","article-title":"Explainable AI (XAI) in healthcare: enhancing trust and transparency in critical decision-making","volume":"23","author":"Adeniran","year":"2024","journal-title":"World J. Adv. Res. Rev."},{"key":"10.1016\/j.ibneur.2025.02.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41419-022-05153-5","article-title":"ER stress and UPR in Alzheimer\u2019s disease: mechanisms, pathogenesis, treatments","volume":"13","author":"Ajoolabady","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib9","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1038\/s41598-023-30904-5","article-title":"Exploiting machine learning models to identify novel Alzheimer\u2019s disease biomarkers and potential targets","volume":"13","author":"Alamro","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.02.002_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-024-51985-w","article-title":"An explainable machine learning approach for Alzheimer\u2019s disease classification","volume":"14","author":"Alatrany","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.02.002_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000016","article-title":"To explain or not to explain?\u2014Artificial intelligence explainability in clinical decision support systems","volume":"1","author":"Amann","year":"2022","journal-title":"PLOS Digit. Health"},{"key":"10.1016\/j.ibneur.2025.02.002_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5545.44900","article-title":"The prevention and treatment of cognitive decline and dementia: an overview of recent research on experimental treatments","volume":"51","author":"Andrade","year":"2009","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ibneur.2025.02.002_bib13","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S1474-4422(15)00153-2","article-title":"Prevention of sporadic Alzheimer\u2019s disease: lessons learned from clinical trials and future directions","volume":"14","author":"Andrieu","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304490","article-title":"A computational approach to identify phytochemicals as potential inhibitor of acetylcholinesterase: molecular docking, ADME profiling and molecular dynamics simulations","volume":"19","author":"Azmal","year":"2024","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ibneur.2025.02.002_bib15","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/B978-0-12-416002-6.00021-3","article-title":"In silico models","author":"Barh","year":"2014","journal-title":"Anim. Biotechnol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JAD-200133","article-title":"Pharmaceutical treatment for Alzheimer\u2019s disease and related dementias: utilization and disparities","volume":"76","author":"Barthold","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib17","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1152\/jn.1999.82.6.2914","article-title":"Computational model of the serotonergic modulation of sensory neurons in aplysia","volume":"82","author":"Baxter","year":"1999","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib18","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.3390\/pharmaceutics15122658","article-title":"Drug delivery to the brain: recent advances and unmet challenges","volume":"15","author":"Bhunia","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ibneur.2025.02.002_bib19","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.0308512100","article-title":"Incipient Alzheimer\u2019s disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses","volume":"101","author":"Blalock","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib20","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.csbj.2023.11.045","article-title":"A holistic approach to understanding immune-mediated inflammatory diseases: bioinformatic tools to integrate omics data","volume":"23","author":"Borrego-Yaniz","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ibneur.2025.02.002_bib21","doi-asserted-by":"crossref","unstructured":"Bucholc, M., James, C., Al Khleifat, A., Badhwar, A., Clarke, N., Dehsarvi, A., Madan, C.R., Marzi, S.J., Shand, C., Schilder, B.M., Tamburin, S., Tantiangco, H.M., Lourida, I., Llewellyn, D.J., Ranson, J.M., 2023. Artificial Intelligence for Dementia Research Methods Optimization. ArXiv arXiv:2303.01949v1.","DOI":"10.1002\/alz.13441"},{"key":"10.1016\/j.ibneur.2025.02.002_bib22","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3233\/JAD-170543","article-title":"Oxidative stress, amyloid-\u03b2 peptide, and altered key molecular pathways in the pathogenesis and progression of alzheimer\u2019s disease","volume":"62","author":"Butterfield","year":"2018","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12920-023-01775-6","article-title":"Bioinformatic identification and experiment validation reveal 6 hub genes, promising diagnostic and therapeutic targets for Alzheimer\u2019s disease","volume":"17","author":"Cao","year":"2024","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.ibneur.2025.02.002_bib24","first-page":"457","article-title":"Molecular docking and molecular dynamics simulations in related to leishmania donovani: an update and literature review","volume":"8","author":"Challapa-Mamani","year":"2023","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fninf.2024.1348113","article-title":"A computational model of Alzheimer\u2019s disease at the nano, micro, and macroscales","volume":"18","author":"Chamberland","year":"2024","journal-title":"Front. Neuroinform."},{"issue":"2020","key":"10.1016\/j.ibneur.2025.02.002_bib26","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.ibneur.2025.02.002_bib27","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/aps.2017.28","article-title":"Amyloid beta: structure, biology and structure-based therapeutic development","volume":"38","author":"Chen","year":"2017","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ibneur.2025.02.002_bib28","doi-asserted-by":"crossref","first-page":"e1534","DOI":"10.1016\/S2214-109X(24)00264-X","article-title":"The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories","volume":"12","author":"Chen","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ibneur.2025.02.002_bib29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.neuron.2020.10.008","article-title":"Apolipoprotein E: structural Insights and links to Alzheimer\u2019s Disease Pathogenesis","volume":"109","author":"Chen","year":"2021","journal-title":"Neuron"},{"key":"10.1016\/j.ibneur.2025.02.002_bib30","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.csbj.2023.04.027","article-title":"Accelerating therapeutic protein design with computational approaches toward the clinical stage","volume":"21","author":"Chen","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ibneur.2025.02.002_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s13760-016-0613-6","article-title":"In silico analyses for molecular genetic mechanism and candidate genes in patients with Alzheimer\u2019s disease","volume":"116","author":"Chi","year":"2016","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.ibneur.2025.02.002_bib32","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/biomedicines12010201","article-title":"Anticancer drug discovery based on natural products: from computational approaches to clinical studies","volume":"12","author":"Chunarkar-Patil","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ibneur.2025.02.002_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1065904","article-title":"The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer\u2019s disease","volume":"14","author":"Clark","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Update on hypothetical model of Alzheimer\u2019s disease biomarkers","volume":"12","author":"Clifford","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib35","doi-asserted-by":"crossref","first-page":"15132","DOI":"10.18632\/oncotarget.23738","article-title":"The genes associated with early-onset Alzheimer\u2019s disease","volume":"9","author":"Dai","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ibneur.2025.02.002_bib36","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood\u2013brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fdata.2021.613047","article-title":"Developing an explainable machine learning-based personalised dementia risk prediction model: a transfer learning approach with ensemble learning algorithms","volume":"4","author":"Danso","year":"2021","journal-title":"Front. Big Data"},{"key":"10.1016\/j.ibneur.2025.02.002_bib38","doi-asserted-by":"crossref","first-page":"8298","DOI":"10.3390\/app13148298","article-title":"Alzheimer\u2019s disease diagnosis using machine learning: a survey","volume":"13","author":"Dara","year":"2023","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib39","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1590\/S1980-57642009DN30300003","article-title":"Neurobiological pathways to Alzheimer\u2019s disease: amyloid-beta, TAU protein or both?","volume":"3","author":"de Paula","year":"2009","journal-title":"Dement Neuropsychol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib40","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.ibneur.2025.02.002_bib41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13195-022-01047-y","article-title":"Early diagnosis of Alzheimer\u2019s disease using machine learning: a multi-diagnostic, generalizable approach","volume":"14","author":"Diogo","year":"2022","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.ibneur.2025.02.002_bib42","doi-asserted-by":"crossref","unstructured":"Dixon, D., Sattar, H., Moros, N., Kesireddy, S.R., Ahsan, H., Lakkimsetti, M., Fatima, M., Doshi, D., Sadhu, K., Junaid Hassan, M., n.d. Unveiling the Influence of AI Predictive Analytics on Patient Outcomes: A Comprehensive Narrative Review. Cureus 16, e59954. https:\/\/doi.org\/10.7759\/cureus.59954.","DOI":"10.7759\/cureus.59954"},{"key":"10.1016\/j.ibneur.2025.02.002_bib43","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1038\/s41598-021-82098-3","article-title":"A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer\u2019s disease","volume":"11","author":"El-Sappagh","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.02.002_bib44","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1002\/humu.22118","article-title":"Toward a mtDNA locus-specific mutation database using the LOVD platform","volume":"33","author":"Elson","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ibneur.2025.02.002_bib45","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/biom12111676","article-title":"Linking the amyloid, tau, and mitochondrial hypotheses of Alzheimer\u2019s disease and identifying promising drug targets","volume":"12","author":"Fi\u0161ar","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ibneur.2025.02.002_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bmcl.2018.11.034","article-title":"New approaches for the treatment of Alzheimer\u2019s disease","volume":"29","author":"Fish","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ibneur.2025.02.002_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature23002","article-title":"Cryo-EM structures of tau filaments from Alzheimer\u2019s disease","volume":"547","author":"Fitzpatrick","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2025.02.002_bib48","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3390\/pharmaceutics12060539","article-title":"Review: local tumor necrosis factor-\u03b1 inhibition in inflammatory bowel disease","volume":"12","author":"Gareb","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ibneur.2025.02.002_bib49","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jalz.2017.08.011","article-title":"Knowledge-driven computational modeling in Alzheimer\u2019s disease research: current state and future trends","volume":"13","author":"Geerts","year":"2017","journal-title":"Alzheimer\u2019S. Dement."},{"key":"10.1016\/j.ibneur.2025.02.002_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/GIM.0b013e31821d69b8","article-title":"Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American college of medical genetics and the national society of genetic counselors","volume":"13","author":"Goldman","year":"2011","journal-title":"Genet Med"},{"key":"10.1016\/j.ibneur.2025.02.002_bib51","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1021\/acs.chemrev.3c00550","article-title":"Computational Approaches to Predict Protein\u2013Protein Interactions in Crowded Cellular Environments","volume":"124","author":"Grassmann","year":"2024","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ibneur.2025.02.002_bib52","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13195-021-00900-w","article-title":"Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer\u2019s disease dementia: a systematic review","volume":"13","author":"Grueso","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"10.1016\/j.ibneur.2025.02.002_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13024-020-00391-7","article-title":"Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ibneur.2025.02.002_bib54","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clin. Inter. Aging"},{"key":"10.1016\/j.ibneur.2025.02.002_bib55","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.3390\/app142210121","article-title":"Explainable AI for alzheimer detection: a review of current methods and applications","volume":"14","author":"Hasan Saif","year":"2024","journal-title":"Appl. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib56","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12559-023-10179-8","article-title":"Interpreting Black-Box Models: A Review on Explainable Artificial Intelligence","volume":"16","author":"Hassija","year":"2024","journal-title":"Cogn. Comput."},{"key":"10.1016\/j.ibneur.2025.02.002_bib57","doi-asserted-by":"crossref","first-page":"13973","DOI":"10.1021\/acsomega.0c01381","article-title":"In silico study and pharmacological evaluation of eplerinone as an anti-Alzheimer\u2019s drug in STZ-induced Alzheimer\u2019s disease model","volume":"5","author":"Hira","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ibneur.2025.02.002_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002369","article-title":"Alzheimer\u2019s disease: the challenge of the second century","volume":"3","author":"Holtzman","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"Pt A","key":"10.1016\/j.ibneur.2025.02.002_bib59","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2014.08.025","article-title":"Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and Alzheimer\u2019s diseases","volume":"72","author":"Huang","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pneurobio.2018.05.001","article-title":"The interactions of p53 with tau and A\u00df as potential therapeutic targets for Alzheimer\u2019s disease","volume":"168","author":"Jazvin\u0161\u0107ak Jembrek","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/cts.12884","article-title":"Precision medicine, AI, and the future of personalized health care","volume":"14","author":"Johnson","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108118","article-title":"Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer\u2019s disease","volume":"174","author":"Joshi","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ibneur.2025.02.002_bib63","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.853294","article-title":"Early-stage Alzheimer\u2019s disease prediction using machine learning models","volume":"10","author":"Kavitha","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/j.ibneur.2025.02.002_bib64","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1021\/acschemneuro.8b00121","article-title":"Shedding light on the molecular pathology of amyloid plaques in transgenic Alzheimer\u2019s disease mice using multimodal MALDI imaging mass spectrometry","volume":"9","author":"Kaya","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2015.05.002","article-title":"Cerebral dopamine neurotrophic factor improves long-term memory in APP\/PS1 transgenic mice modeling Alzheimer\u2019s disease as well as in wild-type mice","volume":"291","author":"Kemppainen","year":"2015","journal-title":"Behav. Brain Res"},{"key":"10.1016\/j.ibneur.2025.02.002_bib66","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3390\/cimb45020086","article-title":"Network pharmacological analysis of a new herbal combination targeting hyperlipidemia and efficacy validation in vitro","volume":"45","author":"Kim","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1021\/ci200542m","article-title":"Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms","volume":"52","author":"Kirchmair","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ibneur.2025.02.002_bib68","doi-asserted-by":"crossref","first-page":"3695","DOI":"10.1038\/s41598-023-30892-6","article-title":"Integrated multi-omics analysis of Alzheimer\u2019s disease shows molecular signatures associated with disease progression and potential therapeutic targets","volume":"13","author":"Kodam","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.02.002_bib69","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3233\/JAD-160614","article-title":"Varying degrees of temporoparietal hypometabolism on FDG-PET reveal amyloid-positive logopenic primary progressive aphasia is not a homogeneous clinical entity","volume":"55","author":"Krishnan","year":"2017","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ibneur.2025.02.002_bib70","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12868-017-0394-8","article-title":"In silico repurposing of antipsychotic drugs for Alzheimer\u2019s disease","volume":"18","author":"Kumar","year":"2017","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib71","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1038\/ng.2802","article-title":"Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease","volume":"45","author":"Lambert","year":"2013","journal-title":"Nat. Genet"},{"key":"10.1016\/j.ibneur.2025.02.002_bib72","doi-asserted-by":"crossref","first-page":"11783","DOI":"10.3390\/ijms130911783","article-title":"Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters","volume":"13","author":"Lee","year":"2012","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib73","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.7638622","article-title":"Candidate gene for the chromosome 1 familial Alzheimer\u2019s disease locus","volume":"269","author":"Levy-Lahad","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.ibneur.2025.02.002_bib74","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/S0140-6736(17)31363-6","article-title":"Dementia prevention, intervention, and care","volume":"390","author":"Livingston","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ibneur.2025.02.002_bib75","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.2147\/IJN.S61288","article-title":"Current approaches to enhance CNS delivery of drugs across the brain barriers","volume":"9","author":"Lu","year":"2014","journal-title":"IJN"},{"key":"10.1016\/j.ibneur.2025.02.002_bib76","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1423-0127-18-8","article-title":"The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies","volume":"18","author":"Lu","year":"2011","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41540-024-00397-7","article-title":"A comprehensive review of computational cell cycle models in guiding cancer treatment strategies","volume":"10","author":"Ma","year":"2024","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.ibneur.2025.02.002_bib78","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.3390\/molecules27041210","article-title":"Amyloidosis in Alzheimer\u2019s disease: pathogeny, etiology, and related therapeutic directions","volume":"27","author":"Ma","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ibneur.2025.02.002_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.1058780","article-title":"Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer\u2019s disease","volume":"14","author":"Ma","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib80","doi-asserted-by":"crossref","DOI":"10.2144\/fsoa-2023-0255","article-title":"In silico and pharmacokinetic studies of glucomoringin from Moringa oleifera root for Alzheimer\u2019s disease like pathology","volume":"10","author":"Manogna","year":"2024","journal-title":"Future Sci. OA"},{"key":"10.1016\/j.ibneur.2025.02.002_bib81","doi-asserted-by":"crossref","first-page":"13713","DOI":"10.18632\/oncotarget.24459","article-title":"Computational modeling suggests impaired interactions between NKX2.5 and GATA4 in individuals carrying a novel pathogenic D16N NKX2.5 mutation","volume":"9","author":"Mattapally","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.ibneur.2025.02.002_bib82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ibror.2019.05.003","article-title":"An in silico investigation on the inhibitory potential of the constituents of Pomegranate juice on antioxidant defense mechanism: relevance to neurodegenerative diseases","volume":"6","author":"Mazumder","year":"2019","journal-title":"IBRO Rep."},{"key":"10.1016\/j.ibneur.2025.02.002_bib83","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/jnr.23592","article-title":"Partial depletion of striatal dopamine enhances penetrance of cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease","volume":"93","author":"Melief","year":"2015","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.ibneur.2025.02.002_bib84","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1523\/JNEUROSCI.4098-07.2008","article-title":"A systems level analysis of transcriptional changes in Alzheimer\u2019s disease and normal aging","volume":"28","author":"Miller","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib85","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bbadis.2009.10.006","article-title":"Mitochondrial dysfunction is a trigger of Alzheimer\u2019s disease pathophysiology","volume":"1802","author":"Moreira","year":"2010","journal-title":"Biochim. Et. Biophys. Acta (BBA) - Mol. Basis Dis., Mitochondrial Dysfunct."},{"key":"10.1016\/j.ibneur.2025.02.002_bib86","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.2174\/1381612826666200224112534","article-title":"Drug development for central nervous system diseases using in vitro blood-brain barrier models and drug repositioning","volume":"26","author":"Morofuji","year":"2020","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ibneur.2025.02.002_bib87","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.cmet.2015.05.011","article-title":"Understanding the cellular and molecular mechanisms of physical activity-induced health benefits","volume":"22","author":"Neufer","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ibneur.2025.02.002_bib88","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/ph17010022","article-title":"Computer-aided drug design and drug discovery: a prospective analysis","volume":"17","author":"Niazi","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ibneur.2025.02.002_bib89","article-title":"Blood brain barrier: an overview on strategies in drug delivery, realistic in vitro modeling and in vivo live tracking","volume":"4","author":"Pandey","year":"2015","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.ibneur.2025.02.002_bib90","doi-asserted-by":"crossref","first-page":"586","DOI":"10.3390\/cells9030586","article-title":"The potential of computational modeling to predict disease course and treatment response in patients with relapsing multiple sclerosis","volume":"9","author":"Pappalardo","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ibneur.2025.02.002_bib91","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.3390\/ijms232213954","article-title":"Alzheimer\u2019s disease: treatment strategies and their limitations","volume":"23","author":"Passeri","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib92","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.drudis.2020.10.010","article-title":"Artificial intelligence in drug discovery and development","volume":"26","author":"Paul","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ibneur.2025.02.002_bib93","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3390\/brainsci12070827","article-title":"Computational analysis of pathogenetic pathways in alzheimer\u2019s disease and prediction of potential therapeutic drugs","volume":"12","author":"Petralia","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib94","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nrd4051","article-title":"Validating therapeutic targets through human genetics","volume":"12","author":"Plenge","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ibneur.2025.02.002_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073631","article-title":"Investigating interventions in Alzheimer\u2019s disease with computer simulation models","volume":"8","author":"Proctor","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.ibneur.2025.02.002_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer\u2019s disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialog-. Clin. Neurosci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102776","article-title":"Artificial intelligence for drug discovery and development in Alzheimer\u2019s disease","volume":"85","author":"Qiu","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib98","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1002\/alz.13790","article-title":"Gene networks and systems biology in Alzheimer\u2019s disease: insights from multi-omics approaches","volume":"20","author":"Rahimzadeh","year":"2024","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.ibneur.2025.02.002_bib99","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4069","article-title":"Neurophysiological signatures in Alzheimer\u2019s disease are distinctly associated with TAU, amyloid-\u03b2 accumulation, and cognitive decline","volume":"12","author":"Ranasinghe","year":"2020","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.ibneur.2025.02.002_bib100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.ibneur.2025.02.002_bib101","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3390\/pharmaceutics13040492","article-title":"Delivery of therapeutic agents to the central nervous system and the promise of extracellular vesicles","volume":"13","author":"Ren\u00e9","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ibneur.2025.02.002_bib102","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3390\/biom12101442","article-title":"Introduction to traditional medicine and their role in prevention and treatment of emerging and re-emerging diseases","volume":"12","author":"Rizvi","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ibneur.2025.02.002_bib103","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/24\/45\/452002","article-title":"Artificial intelligence in nanotechnology","volume":"24","author":"Sacha","year":"2013","journal-title":"Nanotechnology"},{"key":"10.1016\/j.ibneur.2025.02.002_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.compeleceng.2024.109370","article-title":"A review of explainable Artificial Intelligence in healthcare","volume":"118","author":"Sadeghi","year":"2024","journal-title":"Comput. Electr. Eng."},{"key":"10.1016\/j.ibneur.2025.02.002_bib105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","article-title":"Computational approaches streamlining drug discovery","volume":"616","author":"Sadybekov","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ibneur.2025.02.002_bib106","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3390\/pr9010071","article-title":"Molecular dynamics simulations in drug discovery and pharmaceutical development","volume":"9","author":"Salo-Ahen","year":"2021","journal-title":"Processes"},{"key":"10.1016\/j.ibneur.2025.02.002_bib107","doi-asserted-by":"crossref","first-page":"11509","DOI":"10.1021\/ja047286i","article-title":"In silico assembly of Alzheimer\u2019s A\u03b216-22 peptide into \u03b2-sheets","volume":"126","author":"Santini","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ibneur.2025.02.002_bib108","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/0019-5545.49444","article-title":"New drug discovery for Alzheimer\u2019s disease: challenges and hopes","volume":"51","author":"Sathyanarayana Rao","year":"2009","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ibneur.2025.02.002_bib109","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1021\/cb400080f","article-title":"Untangling amyloid-\u03b2, tau, and metals in Alzheimer\u2019s disease","volume":"8","author":"Savelieff","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib110","doi-asserted-by":"crossref","first-page":"12924","DOI":"10.3390\/ijms232112924","article-title":"Amyloid beta in aging and Alzheimer\u2019s disease","volume":"23","author":"Sehar","year":"2022","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib111","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/s41591-023-02505-2","article-title":"Emerging diagnostics and therapeutics for Alzheimer disease","volume":"29","author":"Self","year":"2023","journal-title":"Nat. Med"},{"key":"10.1016\/j.ibneur.2025.02.002_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.pneurobio.2022.102270","article-title":"Amyloid \u03b2, Tau, and \u03b1-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases","volume":"214","author":"Sengupta","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ibneur.2025.02.002_bib113","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ebiom.2016.03.035","article-title":"The role of amyloid-\u03b2 oligomers in toxicity, propagation, and immunotherapy","volume":"6","author":"Sengupta","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ibneur.2025.02.002_bib114","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jconrel.2022.08.051","article-title":"Recent advances in drug delivery and targeting to the brain","volume":"350","author":"Sethi","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.ibneur.2025.02.002_bib115","article-title":"Advances in Artificial Intelligence (AI)-assisted approaches in drug screening","volume":"2","author":"Singh","year":"2024","journal-title":"Artif. Intell. Chem."},{"key":"10.1016\/j.ibneur.2025.02.002_bib116","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1124\/pr.112.007336","article-title":"Computational methods in drug discovery","volume":"66","author":"Sliwoski","year":"2014","journal-title":"Pharm. Rev."},{"key":"10.1016\/j.ibneur.2025.02.002_bib117","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ibneur.2025.02.002_bib118","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.3390\/molecules24234410","article-title":"Future therapeutic perspectives into the alzheimer\u2019s disease targeting the oxidative stress hypothesis","volume":"24","author":"Teixeira","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ibneur.2025.02.002_bib119","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/pharmaceutics14050987","article-title":"Current strategies to enhance delivery of drugs across the blood\u2013brain barrier","volume":"14","author":"Teleanu","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ibneur.2025.02.002_bib120","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/9985719","article-title":"In silico identification of a potential TNF-alpha binder using a structural similarity: a potential drug repurposing approach to the management of Alzheimer\u2019s disease","volume":"2024","author":"Tettevi","year":"2024","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.ibneur.2025.02.002_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27880","article-title":"In silico molecular docking and dynamic simulation of anti-cholinesterase compounds from the extract of catunaregam spinosa for possible treatment of Alzheimer\u2019s disease","volume":"10","author":"Thandivel","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ibneur.2025.02.002_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/869269","article-title":"Drug delivery systems, CNS protection, and the blood brain barrier","volume":"2014","author":"Upadhyay","year":"2014","journal-title":"Biomed. Res Int"},{"key":"10.1016\/j.ibneur.2025.02.002_bib123","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1109\/72.788640","article-title":"An overview of statistical learning theory","volume":"10","author":"Vapnik","year":"1999","journal-title":"IEEE Trans. Neural Netw."},{"key":"10.1016\/j.ibneur.2025.02.002_bib124","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/life14020233","article-title":"Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery","volume":"14","author":"Visan","year":"2024","journal-title":"Life"},{"key":"10.1016\/j.ibneur.2025.02.002_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12559-023-10192-x","article-title":"Explainable artificial intelligence in alzheimer\u2019s disease classification: a systematic review","volume":"16","author":"Viswan","year":"2024","journal-title":"Cogn. Comput."},{"key":"10.1016\/j.ibneur.2025.02.002_bib126","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer\u2019s disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ibneur.2025.02.002_bib127","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.3390\/pharmaceutics15071916","article-title":"Artificial intelligence in pharmaceutical technology and drug delivery design","volume":"15","author":"Vora","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ibneur.2025.02.002_bib128","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.3390\/molecules28124773","article-title":"Identification mechanism of BACE1 on inhibitors probed by using multiple separate molecular dynamics simulations and comparative calculations of binding free energies","volume":"28","author":"Wang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ibneur.2025.02.002_bib129","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1179\/016164106X130515","article-title":"Interventions for heart disease and their effects on Alzheimer\u2019s disease","volume":"28","author":"Wolozin","year":"2006","journal-title":"Neurol. Res"},{"key":"10.1016\/j.ibneur.2025.02.002_bib130","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/j.csbj.2023.02.041","article-title":"Network Proximity-based computational pipeline identifies drug candidates for different pathological stages of Alzheimer\u2019s disease","volume":"21","author":"Wu","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ibneur.2025.02.002_bib131","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/bioengineering11030219","article-title":"A comprehensive review on synergy of multi-modal data and AI technologies in medical diagnosis","volume":"11","author":"Xu","year":"2024","journal-title":"Bioengineering"},{"key":"10.1016\/j.ibneur.2025.02.002_bib132","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1429869","article-title":"The role of bioactive compounds in natural products extracted from plants in cancer treatment and their mechanisms related to anticancer effects","volume":"2022","author":"Yuan","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.ibneur.2025.02.002_bib133","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41540-022-00247-4","article-title":"Computational systems biology in disease modeling and control, review and perspectives","volume":"8","author":"Yue","year":"2022","journal-title":"npj Syst. Biol. Appl."},{"key":"10.1016\/j.ibneur.2025.02.002_bib134","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/make3030027","article-title":"Deterministic Local Interpretable Model-Agnostic Explanations for Stable Explainability","volume":"3","author":"Zafar","year":"2021","journal-title":"Mach. Learn. Knowl. Extr."},{"key":"10.1016\/j.ibneur.2025.02.002_bib135","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41598-023-47069-w","article-title":"In silico anti-alzheimer study of phytochemicals from Lamiaceae family through GSK3-\u03b2 inhibition","volume":"14","author":"Zareei","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ibneur.2025.02.002_bib136","article-title":"Unearthing of key genes driving the pathogenesis of Alzheimer\u2019s disease via bioinformatics","volume":"12","author":"Zhao","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ibneur.2025.02.002_bib137","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.3390\/ijms25094969","article-title":"The enigma of tau protein aggregation: mechanistic insights and future challenges","volume":"25","author":"Zheng","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ibneur.2025.02.002_bib138","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/life14060686","article-title":"A holistic in silico and in vivo approach to exploring the antidiabetic, antioxidant, and hepatoprotective properties of rose of sharon","volume":"14","author":"Ziyanok-Demirtas","year":"2024","journal-title":"Life"}],"container-title":["IBRO Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266724212500020X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266724212500020X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T07:37:44Z","timestamp":1784360264000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266724212500020X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":138,"alternative-id":["S266724212500020X"],"URL":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.02.002","relation":{},"ISSN":["2667-2421"],"issn-type":[{"value":"2667-2421","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing Alzheimer's Therapy: Computational strategies and treatment innovations","name":"articletitle","label":"Article Title"},{"value":"IBRO Neuroscience Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ibneur.2025.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Brain Research Organization.","name":"copyright","label":"Copyright"}]}}